Updated:
Clinipace
Clinipace is based in Morrisville; the profile covers headquarters, registration, AUM band and key contacts for private-markets fundraising.
Overview
Caidya is aligned with biopharma innovators and helps them navigate the constant change in the drug development process.
General information
Location
Region
North America
Country
United States
City
Morrisville
Corporate office
Morrisville, NC, United States
Additional offices
Shanghai · Beijing · Menlo Park · Birmingham · Durham · Gainesville · Bala Cynwyd · Boston · Guangzhou · Burlingame · Fort Worth · Palo Alto · New York · Oakland
Principals
Barbara Lopez Kunz
Chief Executive Officer
Sharon Moore
Chief Medical Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Clinipace / Caidya?
Barbara Lopez Kunz serves as Chief Executive Officer and leads the firm. Sharon Moore, M.D., MBA, MPH, is Chief Medical Officer. The firm is not an investment entity; it is a contract research organization serving biopharma clients.
What investment stages does Clinipace typically target?
Clinipace does not invest in companies. It provides clinical trial services across all development stages: early phase, Phase II/III, and post-approval studies.
Which therapeutic areas does Clinipace focus on?
Clinipace lists expertise in oncology & hematology, rare diseases, dermatology, cell and gene therapy, cardiology, gastroenterology, infectious diseases, nephrology, neurology, pediatrics, respiratory, and women’s health (per firm website).
Where does Clinipace operate globally?
The firm conducts studies in over 40 countries and regions. It maintains offices in the United States, China, and Europe, including locations in Morrisville, Shanghai, Beijing, and Menlo Park.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: